Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
PaperCitations, authors & open-access status
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,547 citations, 2018 year and closed oa status.
2,547
Citations
2018
Year
closed
OA Status